Curanex regains Nasdaq compliance after reverse stock split
Curanex Pharmaceuticals regained Nasdaq compliance after a 1-for-20 reverse stock split restored its $1.00 minimum bid price.
Curanex Pharmaceuticals regained Nasdaq compliance after a 1-for-20 reverse stock split that restored its $1.00 minimum bid price.Key Highlights:Original SEC Filing: Curanex Pharmaceuticals Inc [ CURX ] - 8-K - Sep.
04, 2026This is an AI-powered summary.
It may contain inaccuracies.
Consider verify…